Nuclear translocation of αN-catenin by the novel zinc finger transcriptional repressor ZASC1

被引:17
作者
Bogaerts, S [1 ]
Vanlandschoot, A [1 ]
van Hengel, J [1 ]
van Roy, F [1 ]
机构
[1] State Univ Ghent VIB, Dept Mol Biomed Res,Mol Cell Biol Unit, B-9052 Ghent, Belgium
关键词
alpha-catenin; C2H2 zinc finger; nuclear translocation; ANC_2H01;
D O I
10.1016/j.yexcr.2005.06.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Alpha-catenins anchor the transmembrane cell-cell adhesion molecule E-cadherin indirectly to the actin cytoskeleton through interaction with beta-catenin or plakoglobin. Three different alpha-catenins are known at present: alpha E-, alpha T-, and alpha N-catenin. Despite their different expression patterns, no functional differences between the alpha-catenins are known.]it a yeast two-hybrid screening with aN-catenin as bait, we identified the Cys(2)-His(2) zinc finger protein ZASC1. The mRNA and protein of ZASC1 were ubiquitously expressed in various cell lines and human tissues. Our results suggest an association of the ZASCI protein with DNA, and luciferase reporter assays revealed that ZASCI is a transcriptional repressor. Upon transient overexpression, the ZASCI protein localized in the nucleus, to where it was able to recruit cytoplasmic alpha N-catenin. Neither the highly related alpha E-catenin nor alpha T-catenin interacted with ZASC1. By interchanging parts of alpha N-catenin and alpha E-catenin cDNAs, we were able to narrow down the interaction region of alpha N-catenin to two limited amino-terminal regions. On the other hand, the interaction of ZASCI with alpha N-catenin can be mediated by the domain comprising zinc fingers six to eight of ZASC1. The interaction and nuclear cotranslocation of a neural alpha-catenin with a putative proto-oncogene product as reported here provides novel insights into the signaling functions of alpha-catenins. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 59 条
[1]   Stability of dendritic spines and synaptic contacts is controlled by αN-catenin [J].
Abe, K ;
Chisaka, O ;
van Roy, F ;
Takeichi, M .
NATURE NEUROSCIENCE, 2004, 7 (04) :357-363
[2]  
Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.3.CO
[3]  
2-D
[4]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[5]   A TRANSFERABLE SILENCING DOMAIN IS PRESENT IN THE THYROID-HORMONE RECEPTOR, IN THE V-ERBA ONCOGENE PRODUCT AND IN THE RETINOIC ACID RECEPTOR [J].
BANIAHMAD, A ;
KOHNE, AC ;
RENKAWITZ, R .
EMBO JOURNAL, 1992, 11 (03) :1015-1023
[6]   RETINOIC ACID MODULATES BOTH INVASION AND PLASMA-MEMBRANE RUFFLING OF MCF-7 HUMAN MAMMARY-CARCINOMA CELLS-INVITRO [J].
BRACKE, ME ;
VANLAREBEKE, NA ;
VYNCKE, BM ;
MAREEL, MM .
BRITISH JOURNAL OF CANCER, 1991, 63 (06) :867-872
[7]   POORLY DIFFERENTIATED COLON-CARCINOMA CELL-LINES DEFICIENT IN ALPHA-CATENIN EXPRESSION EXPRESS HIGH-LEVELS OF SURFACE E-CADHERIN BUT LACK CA2+-DEPENDENT CELL-CELL ADHESION [J].
BREEN, E ;
CLARKE, A ;
STEELE, G ;
MERCURIO, AM .
CELL ADHESION AND COMMUNICATION, 1993, 1 (03) :239-250
[8]  
Bubeck P, 1997, J CELL SCI, V110, P1361
[9]   Expression of wild-type alpha-catenin protein in cells with a mutant alpha-catenin gene restores both growth regulation and tumor suppressor activities [J].
Bullions, LC ;
Notterman, DA ;
Chung, LS ;
Levine, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) :4501-4508
[10]   α-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease [J].
Busby, V ;
Goossens, S ;
Nowotny, P ;
Hamilton, G ;
Smemo, S ;
Harold, D ;
Turic, D ;
Jehu, L ;
Myers, A ;
Womick, M ;
Woo, D ;
Compton, D ;
Doil, LM ;
Tacey, KM ;
Lau, KF ;
Al-Saraj, S ;
Killick, R ;
Pickering-Brown, S ;
Moore, P ;
Hollingworth, P ;
Archer, N ;
Foy, C ;
Walter, S ;
Lendon, C ;
Iwatsubo, T ;
Morris, JC ;
Norton, J ;
Mann, D ;
Janssens, B ;
Hardy, J ;
O'Donovan, M ;
Jones, L ;
Williams, J ;
Holmans, P ;
Owen, MJ ;
Grupe, A ;
Powell, J ;
van Hengel, J ;
Goate, A ;
Van Roy, F ;
Lovestone, S .
NEUROMOLECULAR MEDICINE, 2004, 5 (02) :133-146